A few days ago AstraZeneca company announced, that their vaccine AZD1222 have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so. They made a little voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators, but now days they continued researching’s and testing’s.
“AstraZeneca is committed to the safety of trial participants and the highest standards of conduct in clinical trials. The Company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” – company said.
3 COVID-19 Vaccine Acceptability Leaders
To date only candidate on COVID-19 vaccine is going on Phase III of testing’s. These companies are AstraZeneca, Moderna and Pfizer. Need to be said that candidate AZD1222 was temporarily suspended, and Moderna recently shares were down about 8.5%, but they’re still up nearly 200% for the year.
“As we are in the midst of a global buildout of capacity analogous to a Manhattan Project for vaccines, we see excess capacity, high competitive intensity, and limited pricing power as likely long-term structural features of vaccine end-markets, presenting secular challenges to a sub-scale player such as MRNA,” Leerink analyst Mani Foroohar said.
All these factors have a direct control acceptability of a COVID-19 vaccine among adults in the United States.
69% Of Adults Are Ready For COVID-19 Vaccination
According to The Ohio State University research now about 69% of adults is ready for COVID-19 vaccination.
“Overall, 69% of participants were willing to get a COVID-19 vaccine. Participants were more likely to be willing to get vaccinated if they thought their healthcare provider would recommend vaccination or if they were moderate in their political leaning. Participants were also more likely to be willing to get vaccinated if they reported higher levels of perceived likelihood getting a COVID-19 infection in the future, perceived severity of COVID-19 infection, or perceived effectiveness of a COVID-19 vaccine. Participants were less likely to be willing to get vaccinated if they were non-Latinx black or reported a higher level of perceived potential vaccine harms,” – according to the researches results.
Another statistic, from CBS News said, that: “Just 21% of voters nationwide now say they would get a vaccine as soon as possible if one became available at no cost, down from 32% in late July. Most would consider it but would wait to see what happens to others before getting one.”
“As the coronavirus outbreak continues, voters now have less trust in some key entities for information about the virus, with a notable drop in trust in the Centers for Disease Control (CDC). Back in March, 86% of voters trusted the CDC for accurate information about the virus, but today just 54% do. Trust is down across all major demographics, including both Democrats and Republicans. Fewer also trust the media, their state’s governor and President Trump for accurate information about the coronavirus, compared to the spring,” – CBS News concludes.
